UMGCCC and AstraZeneca Partner to Enhance Community-Based Lung Cancer Screening and Detection for Marylanders at High Risk
April 16, 2024 | Deborah Kotz
With only a small percentage of Marylanders at high risk for lung cancer getting the recommended annual screening, the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) today launched a new statewide effort to increase annual screenings.
Read the full story at: https://www.umms.org/umgccc/news/2024/umgccc-partners-with-astrazeneca
Contact
Karen Warmkessel: kwarmkessel@umm.edu 410-328-8919
Deborah Kotz: dkotz@som.umaryland.edu 410-706-4255